A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer

Arlene O. Siefker-Radtke; Colin P. Dinney; Yu Shen; Dallas L. Williams; Ashish M. Kamat; H. Barton Grossman; Randall E. Millikan

doi:10.1002/cncr.27751

A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer

Cancer ◽

10.1002/cncr.27751 ◽

2012 ◽

Vol 119 (3) ◽

pp. 540-547 ◽

Cited By ~ 55

Author(s):

Arlene O. Siefker-Radtke ◽

Colin P. Dinney ◽

Yu Shen ◽

Dallas L. Williams ◽

Ashish M. Kamat ◽

...

Keyword(s):

Clinical Trial ◽

Neoadjuvant Chemotherapy ◽

Urothelial Cancer ◽

Locally Advanced ◽

Phase 2 ◽

Phase 2 Clinical Trial ◽

Advanced Urothelial Cancer

Download Full-text

Re: A Phase 2 Clinical Trial of Sequential Neoadjuvant Chemotherapy with Ifosfamide, Doxorubicin, and Gemcitabine Followed by Cisplatin, Gemcitabine, and Ifosfamide in Locally Advanced Urothelial Cancer: Final Results

The Journal of Urology ◽

10.1016/j.juro.2013.08.071 ◽

2013 ◽

Vol 190 (6) ◽

pp. 2019-2019

Author(s):

David P. Wood

Keyword(s):

Clinical Trial ◽

Neoadjuvant Chemotherapy ◽

Urothelial Cancer ◽

Locally Advanced ◽

Phase 2 ◽

Phase 2 Clinical Trial ◽

Advanced Urothelial Cancer

Download Full-text

Results of a prospective phase 2 clinical trial of induction gemcitabine/capecitabine followed by stereotactic ablative radiation therapy in borderline resectable or locally advanced pancreatic adenocarcinoma

Practical Radiation Oncology ◽

10.1016/j.prro.2017.10.001 ◽

2018 ◽

Vol 8 (2) ◽

pp. 95-106 ◽

Cited By ~ 10

Author(s):

Kimmen Quan ◽

Philip Sutera ◽

Karen Xu ◽

Mark E. Bernard ◽

Steven A. Burton ◽

...

Keyword(s):

Clinical Trial ◽

Radiation Therapy ◽

Locally Advanced ◽

Phase 2 ◽

Borderline Resectable ◽

Phase 2 Clinical Trial ◽

Locally Advanced Pancreatic Adenocarcinoma ◽

Prospective Phase ◽

Advanced Pancreatic Adenocarcinoma ◽

Stereotactic Ablative Radiation Therapy

Download Full-text

Neoadjuvant Chemotherapy for Locally Advanced Urothelial Cancer of the Upper Urinary Tract

Urologia Internationalis ◽

10.1159/000282755 ◽

1995 ◽

Vol 55 (2) ◽

pp. 74-77 ◽

Cited By ~ 61

Author(s):

M. Igawa ◽

S. Urakami ◽

H. Shiina ◽

H. Kishi ◽

Y. Himeno ◽

...

Keyword(s):

Urinary Tract ◽

Neoadjuvant Chemotherapy ◽

Urothelial Cancer ◽

Locally Advanced ◽

Upper Urinary Tract ◽

Advanced Urothelial Cancer

Download Full-text

A phase II trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine (IAG), followed by cisplatin, gemcitabine and ifosfamide (CGI) in locally advanced urothelial cancer (UC): Final results from the M.D. Anderson Cancer Center

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.5079 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 5079-5079 ◽

Cited By ~ 4

Author(s):

A. O. Siefker-Radtke ◽

R. E. Millikan ◽

A. M. Kamat ◽

Y. Shen ◽

D. L. Williams ◽

...

Keyword(s):

Neoadjuvant Chemotherapy ◽

Phase Ii ◽

Urothelial Cancer ◽

Phase Ii Trial ◽

Locally Advanced ◽

Cancer Center ◽

Advanced Urothelial Cancer

Download Full-text

About the Recently Published Paper on JAMA Oncology “Radioembolization Plus Chemotherapy for First-Line Treatment of Locally Advanced Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial”

CardioVascular and Interventional Radiology ◽

10.1007/s00270-020-02577-4 ◽

2020 ◽

Vol 43 (9) ◽

pp. 1418-1419

Author(s):

Irene Bargellini ◽

Caterina Vivaldi ◽

Laura Crocetti ◽

Gianluca Masi

Keyword(s):

Clinical Trial ◽

Intrahepatic Cholangiocarcinoma ◽

Locally Advanced ◽

Line Treatment ◽

Phase 2 ◽

First Line ◽

Phase 2 Clinical Trial ◽

Published Paper ◽

First Line Treatment

Download Full-text

Sequential therapy of neoadjuvant biochemotherapy with cetuximab, paclitaxel, and cisplatin followed by cetuximab‐based concurrent bioradiotherapy in high‐risk locally advanced oral squamous cell carcinoma: Final analysis of a phase 2 clinical trial

Head & Neck ◽

10.1002/hed.25640 ◽

2019 ◽

Vol 41 (6) ◽

pp. 1703-1712 ◽

Cited By ~ 2

Author(s):

Chia‐Jui Yen ◽

Hsiao‐Hui Tsou ◽

Ching‐Yun Hsieh ◽

Chang‐Yao Chu ◽

Chang‐Fang Chiu ◽

...

Keyword(s):

Clinical Trial ◽

Squamous Cell Carcinoma ◽

High Risk ◽

Oral Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Locally Advanced ◽

Final Analysis ◽

Sequential Therapy ◽

Phase 2 ◽

Phase 2 Clinical Trial

Download Full-text

Comparison of a Novel Tazarotene 0.045% Lotion to Tazarotene 0.1% Cream: Patient-Reported Outcomes from a Phase 2 Clinical Trial

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.3.supp.9 ◽

2019 ◽

Vol 3 ◽

pp. S9

Author(s):

Zoe Draelos ◽

Fran Cook-Bolden ◽

Lawrence Green ◽

Eric Guenin ◽

Gina Martin ◽

...

Keyword(s):

Clinical Trial ◽

Patient Reported Outcomes ◽

Phase 2 ◽

Patient Reported ◽

Phase 2 Clinical Trial

Abstract not available.

Download Full-text

Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

Case Medical Research ◽

10.31525/ct1-nct04283669 ◽

2020 ◽

Author(s):

Keyword(s):

Clinical Trial ◽

Neurofibromatosis Type ◽

Neurofibromatosis Type 2 ◽

Vestibular Schwannomas ◽

Phase 2 ◽

Phase 2 Clinical Trial

Download Full-text

Faculty Opinions recommendation of Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1047842.497861 ◽

2006 ◽

Author(s):

David Sullivan

Keyword(s):

Clinical Trial ◽

Plasmodium Falciparum ◽

Combination Therapy ◽

Falciparum Malaria ◽

Plasmodium Falciparum Malaria ◽

Phase 2 ◽

Phase 2 Clinical Trial ◽

Uncomplicated Plasmodium Falciparum Malaria ◽

Randomized Phase 2

Download Full-text

Faculty Opinions recommendation of Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas: A Phase 2 Clinical Trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727784209.793552909 ◽

2018 ◽

Author(s):

Warren A Chow

Keyword(s):

Clinical Trial ◽

Macrophage Infiltration ◽

Phase 2 ◽

Pathway Activation ◽

Phase 2 Clinical Trial

Download Full-text